scholarly article | Q13442814 |
P2093 | author name string | Ricardo Bentes Azevedo | |
Adriana Bonomo | |||
Triciana Gonçalves-Silva | |||
Sacha Braun Chaves | |||
Ana Carolina Monteiro | |||
Ana Carolina Leal | |||
João P Monteiro | |||
Fabiola Kestelman | |||
Ana Carolina T Mercadante | |||
P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
RANK is essential for osteoclast and lymph node development | Q24598872 | ||
Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer | Q24605866 | ||
Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion | Q27860475 | ||
The blockade of immune checkpoints in cancer immunotherapy | Q27860852 | ||
TRANCE is a TNF family member that regulates dendritic cell and osteoclast function | Q28137948 | ||
The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development | Q28142247 | ||
Matrix-embedded cells control osteoclast formation | Q28247746 | ||
A novel orthotopic model of breast cancer metastasis to bone. | Q52826484 | ||
Spontaneous mammary adenocarcinoma in mice: influence of thymectomy and reconstitution with thymus grafts or spleen cells. | Q53993813 | ||
Treg cells suppress osteoclast formation: a new link between the immune system and bone | Q56900960 | ||
Effect of Early Thymectomy on Development of Mammary Tumours in Mice | Q58964947 | ||
Accelerated development of spontaneous mammary tumors in mice pretreated with mammary tumor tissue and adjuvant | Q78881976 | ||
Diminished forkhead box P3/CD25 double-positive T regulatory cells are associated with the increased nuclear factor-kappaB ligand (RANKL+) T cells in bone resorption lesion of periodontal disease | Q79929436 | ||
Th17 cells, not IL-17+ γδ T cells, drive arthritic bone destruction in mice and humans | Q83155016 | ||
Evidence for osteocyte regulation of bone homeostasis through RANKL expression | Q28247757 | ||
Cancer despite immunosurveillance: immunoselection and immunosubversion | Q28263865 | ||
Microenvironmental regulation of metastasis | Q29547660 | ||
The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited | Q29547915 | ||
Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression | Q29614274 | ||
Metastasis to bone: causes, consequences and therapeutic opportunities | Q29614310 | ||
Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy | Q29618033 | ||
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET | Q29618139 | ||
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand | Q29619331 | ||
New insights into the role of T cells in the vicious cycle of bone metastases | Q30440690 | ||
Mechanisms of bone metastasis | Q33977526 | ||
Collagen induced arthritis increases secondary metastasis in MMTV-PyV MT mouse model of mammary cancer | Q34000467 | ||
LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study | Q34096856 | ||
Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor | Q34352016 | ||
Malignant cells facilitate lung metastasis by bringing their own soil | Q34411553 | ||
Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow | Q34755120 | ||
CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages | Q34995099 | ||
Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling | Q35194008 | ||
IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation | Q35219971 | ||
IMMUNOLOGY OF EXPERIMENTAL TUMORS. | Q35434728 | ||
Expression of tumour-specific antigens underlies cancer immunoediting | Q35785378 | ||
In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche. | Q37051371 | ||
ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma | Q37101727 | ||
Radiologic measurements of tumor response to treatment: practical approaches and limitations. | Q37113203 | ||
Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene | Q37265676 | ||
T-lymphocyte interaction with stromal, bone and hematopoietic cells in the bone marrow. | Q37333685 | ||
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting | Q37418530 | ||
Osteoimmunology and the effects of the immune system on bone | Q37626412 | ||
RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis | Q39365550 | ||
A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma | Q39483693 | ||
Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction | Q41927546 | ||
Normal hematopoiesis is maintained by activated bone marrow CD4+ T cells | Q42469876 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | osteolysis | Q2035084 |
metastatic breast cancer | Q12859063 | ||
P304 | page(s) | e68171 | |
P577 | publication date | 2013-01-01 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | T cells induce pre-metastatic osteolytic disease and help bone metastases establishment in a mouse model of metastatic breast cancer | |
P478 | volume | 8 |